Sung Won Lee

Samsung Medical Center

Papers

1

Total Citations

33

H-Index

1

About

Sung Won Lee is a leading urological oncologist whose research has significantly advanced the quality-of-life assessment for prostate cancer patients. His primary focus lies in developing and validating culturally adapted patient-reported outcome measures, with his most cited work being the "Development and Validation of the Korean Version of Expanded Prostate Cancer Index Composite" (2010, 33 citations). This seminal study addressed a critical gap by creating a unified, validated Korean-language tool to measure health-related quality of life after prostate cancer treatment, covering urinary, bowel, sexual, and hormonal domains. By translating and rigorously validating the internationally recognized EPIC instrument, Lee enabled Korean clinicians and researchers to accurately assess treatment outcomes from the patient's perspective, facilitating cross-cultural comparisons and improving clinical decision-making. His contributions have been instrumental in elevating the standard of care for prostate cancer survivors in Korea, ensuring that quality-of-life considerations are systematically integrated into treatment evaluations. Lee's work exemplifies how methodologically sound instrument development can bridge cultural and linguistic barriers in oncology research.

Research Focus

Key Achievements

1
H-Index
1
Papers
33
Total Citations
33
Avg Citations/Paper
🏆 Most Cited Paper
Development and Validation of the Korean Version of Expanded Prostate Cancer Index Composite: Questionnaire Assessing Health-Related Quality of Life after Prostate Cancer Treatment
33 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 5
🏛 Institutions: Samsung Medical Center

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago